Standout Papers

Alendronate mechanism of action: geranylgeraniol, an intermediate in the mevalonate pathway, p... 1999 2026 2008 2017 562
  1. Alendronate mechanism of action: geranylgeraniol, an intermediate in the mevalonate pathway, prevents inhibition of osteoclast formation, bone resorption, and kinase activation in vitro (1999)
    John Fisher, Michael J. Rogers et al. Proceedings of the National Academy of Sciences

Immediate Impact

23 by Nobel laureates 25 from Science/Nature 64 standout
Sub-graph 1 of 19

Citing Papers

Genome-Scale Identification of SARS-CoV-2 and Pan-coronavirus Host Factor Networks
2020 StandoutNobel
eIF3d is an mRNA cap-binding protein that is required for specialized translation initiation
2016 StandoutNatureNobel
2 intermediate papers

Works of A A Reszka being referenced

Alendronate mechanism of action: geranylgeraniol, an intermediate in the mevalonate pathway, prevents inhibition of osteoclast formation, bone resorption, and kinase activation in vitro
1999 Standout
Overexpression of mitogen-activated protein kinase kinase (MAPKK) and its mutants in NIH 3T3 cells. Evidence that MAPKK involvement in cellular proliferation is regulated by phosphorylation of serine residues in its kinase subdomains VII and VIII.
1994 Nobel

Author Peers

Author Last Decade Papers Cites
A A Reszka 1354 851 471 480 12 2.3k
John E. Skonier 1423 593 147 223 15 2.2k
Päivi T. Lakkakorpi 1592 887 354 564 23 2.0k
M. Mehrdad Tondravi 1416 891 240 274 19 2.2k
Johannes Schlöndorff 1748 754 349 508 39 3.2k
K T Yeo 1875 610 211 305 15 3.2k
Yoshiaki Kawano 2242 620 586 287 37 3.3k
Lorraine Lipfert 1179 400 505 1164 20 2.3k
Joni D. Mott 1250 951 392 283 25 2.7k
Tatsuo Suda 3402 2434 147 186 14 4.4k
Derrick S. Grant 1779 592 563 847 28 3.4k

All Works

Loading papers...

Rankless by CCL
2026